Browse Drug Recalls
17 FDA drug safety recalls.
FDA Drug Recall Enforcement Database
Browse 17 FDA drug recall enforcement actions. Each entry includes the product description, reason for recall, classification (Class I through III based on severity), recalling firm, and distribution details. Use the filters below to search by year, classification, state, or keyword.
Drug Safety Recalls
Browse 17 FDA drug recalls.
| Date | Product | Reason | Class | Firm |
|---|---|---|---|---|
| Nov 30, 2020 | PT-141, 10 MG/ML, 2 ML vial, The Guyer Institute of Molecular Medicine, India... | Lack of Assurance of Sterility: due to concerns with production processes which cannot assure ste... | Class II | Advanced Nutriceuticals, LLC |
| Nov 30, 2020 | IPAMORELIN, 2000 MCG/ML, 5 ML vial, The Guyer Institute of Molecular Medicine... | Lack of Assurance of Sterility: due to concerns with production processes which cannot assure ste... | Class II | Advanced Nutriceuticals, LLC |
| Nov 30, 2020 | NANDROLONE, 200 MCG/ML, 2 ML, The Guyer Institute of Molecular Medicine, Indi... | Lack of Assurance of Sterility: due to concerns with production processes which cannot assure ste... | Class II | Advanced Nutriceuticals, LLC |
| Nov 30, 2020 | DSIP, 1000 MCG/ML, 5 ML vial, The Guyer Institute of Molecular Medicine, Indi... | Lack of Assurance of Sterility: due to concerns with production processes which cannot assure ste... | Class II | Advanced Nutriceuticals, LLC |
| Nov 30, 2020 | Pentosan Polysulfate, 300 MG/ML, 5 ML vial, The Guyer Institute of Molecular ... | Lack of Assurance of Sterility: due to concerns with production processes which cannot assure ste... | Class II | Advanced Nutriceuticals, LLC |
| Nov 30, 2020 | GHK-CU, 10 MG/ML, 5 ML vial, The Guyer Institute of Molecular Medicine, India... | Lack of Assurance of Sterility: due to concerns with production processes which cannot assure ste... | Class II | Advanced Nutriceuticals, LLC |
| Nov 30, 2020 | FGL, 10 MG/ML, 3 ML vial, The Guyer Institute of Molecular Medicine, Indianap... | Lack of Assurance of Sterility: due to concerns with production processes which cannot assure ste... | Class II | Advanced Nutriceuticals, LLC |
| Nov 30, 2020 | B12 for Injection, 2 MG/ML, 10 ML vial, The Guyer Institute of Molecular Medi... | Lack of Assurance of Sterility: due to concerns with production processes which cannot assure ste... | Class II | Advanced Nutriceuticals, LLC |
| Nov 30, 2020 | CJC-1295, 2000 MCG/ML, 5 ML vial, The Guyer Institute of Molecular Medicine, ... | Lack of Assurance of Sterility: due to concerns with production processes which cannot assure ste... | Class II | Advanced Nutriceuticals, LLC |
| Nov 30, 2020 | HIGH DOSE B12, 10 MG/ML, 10 ML vial, The Guyer Institute of Molecular Medicin... | Lack of Assurance of Sterility: due to concerns with production processes which cannot assure ste... | Class II | Advanced Nutriceuticals, LLC |
| Nov 30, 2020 | THYMOSIN BETA - 4, 2000 MCG/ML, 5 ML vial, The Guyer Institute of Molecular M... | Lack of Assurance of Sterility: due to concerns with production processes which cannot assure ste... | Class II | Advanced Nutriceuticals, LLC |
| Nov 30, 2020 | CEREBROLYSIN, 107.5 MG/ML, 10 ML vial, The Guyer Institute of Molecular Medic... | Lack of Assurance of Sterility: due to concerns with production processes which cannot assure ste... | Class II | Advanced Nutriceuticals, LLC |
| Nov 30, 2020 | AOD-9604, 1200 MCG/ML, 5 ML vial The Guyer Institute of Molecular Medicine, I... | Lack of Assurance of Sterility: due to concerns with production processes which cannot assure ste... | Class II | Advanced Nutriceuticals, LLC |
| Nov 30, 2020 | LL-37, 2000 MCG/ML, 2 ML vial, The Guyer Institute of Molecular Medicine, Ind... | Lack of Assurance of Sterility: due to concerns with production processes which cannot assure ste... | Class II | Advanced Nutriceuticals, LLC |
| Nov 30, 2020 | THYMOSIN ALPHA, 2000 MCG/ML, 5 ML vial, The Guyer Institute of Molecular Medi... | Lack of Assurance of Sterility: due to concerns with production processes which cannot assure ste... | Class II | Advanced Nutriceuticals, LLC |
| Nov 30, 2020 | GHRP, 2000 MCG/ML, 5 ML vial, The Guyer Institute of Molecular Medicine, Indi... | Lack of Assurance of Sterility: due to concerns with production processes which cannot assure ste... | Class II | Advanced Nutriceuticals, LLC |
| Nov 30, 2020 | BPC-157, 2000 MCG/ML, 5 ML vial, The Guyer Institute of Molecular Medicine, I... | Lack of Assurance of Sterility: due to concerns with production processes which cannot assure ste... | Class II | Advanced Nutriceuticals, LLC |
Frequently Asked Questions
When a drug safety issue is identified — through FDA inspections, laboratory testing, adverse event reports, or manufacturer quality checks — the responsible company issues a recall to remove the affected products from the market. Pharmacies pull the product from shelves, and consumers are advised to contact their healthcare provider for alternatives.
The leading causes include cGMP deviations, impurity contamination (including nitrosamines like NDMA), failed dissolution or stability testing, sterility issues, potency problems, labeling errors, and foreign particle contamination.
Use the search and filter tools on this page to look up specific medications, active ingredients, or manufacturers. Each recall entry includes the product description, lot numbers, and distribution details.